The Indonesia Bariatric Surgery Devices Market was valued at $16 Mn in 2023 and is projected to grow at a CAGR of 5.2% from 2023 to 2023, to $22.8 Mn by 2030. The market for bariatric surgical devices is being driven primarily by increased adult obesity rates, which are a result of changing lifestyles and consuming excessive amounts of calories. Over the course of the projection period, it is also expected that the demand for bariatric operations will increase as a result of growing public awareness of the harmful food and beverage options available in the market and how they affect body mass index (BMI), which will fuel the expansion of the bariatric surgery devices market. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
The China Cough Hypersensitivity Syndrome Therapeutics Market was valued at $0.651 Bn in 2022 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $1.153 Bn by 2030. The key drivers of this industry include the increasing prevalence of Cough Hypersensitivity Syndrome, the development of advanced therapeutics, and expanding healthcare infrastructure. The industry is primarily dominated by players such as Johnson & Johnson, GSK, Merck, Novartis, AstraZeneca, and Pfizer among others.
The Saudi Arabia Mental Health Apps Market was valued at $105.4 Mn in 2023 and is predicted to grow at a CAGR of 16.7% from 2023 to 2030, to $310.7 Mn by 2030. The key drivers of this industry include reduced stigma, increasing smartphone penetration, and a shortage of professionals. The industry is primarily dominated by players such as Labayh, Tuhoon, Qareboon, and Psychological Health among others.
UK CT Scan Market was valued at $119.86 Mn in 2023 and is predicted to grow at a CAGR of 5.87% from 2023 to 2030, to $178.68 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, technological advancements in CT scanners, and the growing geriatric population. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
The Japan Bariatric Surgery Devices Marketwas valued at $165.3 Mn in 2023 and is projected to grow at a CAGR of 5.7% from 2023 to 2023, to $243.7 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Medtronic, B. Braun, Olympus Corporation among others.
The France Cough Hypersensitivity Syndrome Therapeutics Market was valued at $223 Mn in 2022 and is predicted to grow at a CAGR of 4.9% from 2023 to 2030, to $327 Mn by 2030. The main factors driving this industry include the rising prevalence of Cough Hypersensitivity Syndrome, supportive government initiatives, and the development of advanced therapeutics. The industry is primarily dominated by players such as Roche, Pfizer, Sanofi, Novartis, Johnson & Johnson, and GSK among others.
China CT Scan Market was valued at $370.59 Mn in 2023 and is predicted to grow at a CAGR of 9.37% from 2023 to 2030, to $693.71 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing population and aging, and integration of AI and machine learning. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
The Malaysia Bariatric Surgery Devices Market was valued at $4.3 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $6.2 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
The Mexico Lipid Disorder Therapeutics Market was valued at $60.6 Mn in 2023 and is predicted to grow at a CAGR of 12.63% from 2023 to 2030, to $139.3 Mn by 2030. Mexico Lipid Disorder Therapeutics Market is growing due to Growing Awareness and Diagnosis Rates, Collaborations, Partnerships, and Increasing Healthcare Expenditure. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
The Germany Cough Hypersensitivity Syndrome Therapeutics Market was valued at $296 Mn in 2022 and is predicted to grow at a CAGR of 4.1% from 2023 to 2030, to $409 Mn by 2030. The key drivers of this industry include the increasing prevalence of Cough Hypersensitivity Syndrome, expanding government initiatives, and high unmet medical needs. The industry is primarily dominated by players such as Roche, Pfizer, Teva, Novartis, Johnson & Johnson, and GSK among others.
The Brazil Mental Health Apps Market was valued at $155 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $443.38 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and rising interest in preventive care. The industry is primarily dominated by players such as Headspace, Calm, Meditopia, and Meditation: Lojong among others.
Indonesia CT Scan Market was valued at $27.66Mn in 2023 and is predicted to grow at a CAGR of 7.87% from 2023 to 2030, to $47.01Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing population and hospital development. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
The Singapore Bariatric Surgery Devices Market was valued at $3.2 Mn in 2023 and is projected to grow at a CAGR of 5.8% from 2023 to 2023, to $4.7 Mn by 2030. The growing prevalence of adult obesity brought on by changed lifestyle choices and excessive calorie consumption are major drivers propelling the market for bariatric surgical devices. Increased government support and rising public awareness of the unhealthy food and beverage options available in the market and how they affect BMI are expected to fuel the need for bariatric surgeries over the course of the forecast period, which will also propel the expansion of the bariatric surgery devices market. The prominent players in the market are Zimmer Biomet, Boston Scientific, Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
The Indonesia Cough Hypersensitivity Syndrome Therapeutics Market was valued at $49 Mn in 2022 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $77 Mn by 2030. The primary factors propelling this sector comprise the rising prevalence of Cough Hypersensitivity Syndrome, the development of advanced therapeutics, and improving healthcare access. The industry is primarily dominated by players such as Johnson & Johnson, GSK, Sanofi, Novartis, AstraZeneca, Pfizer, and Boehringer Ingelheim among others.
The Mexico Mental Health Apps Market was valued at $93 Mn in 2023 and is predicted to grow at a CAGR of 15.45% from 2023 to 2030, to $254.24 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and reduced stigma. The industry is primarily dominated by players such as Headspace, Calm, Happify, and Yana among others.
Japan CT Scan Market was valued at $286.55 Mn in 2023 and is predicted to grow at a CAGR of 8.37% from 2023 to 2030, to $503 Mn by 2030. The key drivers of this industry include the aging population, rising chronic disease burden, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
The Philippines Bariatric Surgery Devices Market was valued at $5.8 Mn in 2023 and is projected to grow at a CAGR of 5.7% from 2023 to 2023, to $8.6 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Philips, Medline Industries, Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Spain Lipid Disorder Therapeutics Market was valued at $12.1 Mn in 2023 and is predicted to grow at a CAGR of 13.23% from 2023 to 2030, to $28.9 Mn by 2030. Spain Lipid Disorder Therapeutics Market is growing due to Customer preferences, Advancements in Therapeutics, Increased Healthcare Expenditure, and Macroeconomic factors. The industry is primarily dominated by players such as Novartis AG, Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
The Mexico Cough Hypersensitivity Syndrome Therapeutics Market was valued at $122 Mn in 2022 and is predicted to grow at a CAGR of 6.15% from 2023 to 2030, to $196 Mn by 2030. The main factors driving this industry include the increasing prevalence of Cough Hypersensitivity Syndrome, expanding healthcare infrastructure, and the development of advanced therapeutics. The industry is primarily dominated by players such as Roche, Pfizer, Teva, Novartis, Johnson & Johnson, and GSK among others.
The France Mental Health Apps Market was valued at $170.5 Mn in 2023 and is predicted to grow at a CAGR of 14.2% from 2023 to 2030, to $431.9 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and rising interest in preventative care. The industry is primarily dominated by players such as Evoluno, Calm, Teale, and Mental Booster among others.
Malaysia CT Scan Market was valued at $7.41 Mn in 2023 and is predicted to grow at a CAGR of 8.07% from 2023 to 2030, to $12.76 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, and growing technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
The Vietnam Bariatric Surgery Devices Market was valued at $13.3 Mn in 2023 and is projected to grow at a CAGR of 5.43% from 2023 to 2023, to $19.3 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
The UK Lipid Disorder Therapeutics Market was valued at $16.2 Mn in 2023 and is predicted to grow at a CAGR of 12.83% from 2023 to 2030, to $37.8 Mn by 2030. UK Lipid Disorder Therapeutics Market is growing due to the Increasing Prevalence of Cardiovascular Diseases, Government & NHS Support, Technological Advancements, and Personalized Medicine. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
The Saudi Arabia Cough Hypersensitivity Syndrome Therapeutics Market was valued at $138 Mn in 2022 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $244 Mn by 2030. The key drivers of this industry include the surge in prevalence of Cough Hypersensitivity Syndrome, supportive government initiatives, and the emergence of novel therapeutics. The industry is primarily dominated by players such as Sanofi, Pfizer, Almirall, Novartis, Johnson & Johnson, and GSK among others.
The Germany Mental Health Apps Market was valued at $226.92 Mn in 2023 and is predicted to grow at a CAGR of 13.4% from 2023 to 2030, to $547.22 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and healthcare integration. The industry is primarily dominated by players such as MindShift CBT, Headspace, Calm, and 7 Cups among others.